APRN Pharmacology Bundle
The APRN pharmacology bundle features courses relevant to APRNs and RNs, including:
Amid the opioid epidemic, new legislation, guidelines, and regulations for prescribing have been established. APRNs who complete this course will better understand how to assess pain, the most commonly prescribed opioids, their mechanism of action, side effects, and safe prescribing practices.
This course benefits practitioners who want to obtain DEA registration to prescribe opioids in their current practice.
Learn about the GIP GLP-1 medication tirzepatide, more commonly known as Mounjaro. This medication has grown in popularity in recent years due to its impact on weight loss. Providers need to know about the clinical indications for usage, its mechanism of action, and inclusion criteria before prescribing.
In 2017, the Food and Drug Administration approved the use of semaglutide injection (commonly known as Ozempic) to treat Type 2 diabetes.
The drug has been widely accepted due to its positive effects on weight loss and lowering chronic health risks. Several celebrities have also publicly shared their Ozempic-based weight loss journeys.
However, its popularity has caused significant shortages, negatively impacting the lives of the diabetic community, local pharmacies, and healthcare providers.
This continuing education program educates and empowers healthcare providers as it relates to clinical indications, patient education, cost options, and benefit/risk analysis of semaglutide.
Half of people 12 years old and older have reported using an illicit substance at least once, and 21 million Americans experience addiction. Medication Assisted Treatment (MAT) combines counseling and behavioral therapies for addiction with medications used at careful dosages to reduce physical symptoms of cravings and withdrawal.
Nurses learn about the latest research on medications to treat hypertension, the pharmacokinetics of these medications, and considerations for prescribers.
This course provides nurses with the knowledge and skills necessary to address the complex nature of migraines through pharmaceutical interventions.
After completing this course, nurses will be able to:
- Understand the migraine medications and neurobiological and pathophysiological mechanisms underlying migraines.
- Demonstrate the knowledge and skills to ensure patient safety when prescribing and administering migraine medications.
This course provides an overview of medications used to manage and treat asthma. Nurses explore the purpose of asthma medications, stages of asthma clinical presentation, asthmatic medical implications on quality of life, and asthma research.
Gain an understanding of selective serotonin reuptake inhibitors (SSRIs), a type of pharmaceutical drug class used to manage major depressive disorder (MDD). Nurses explore the purpose of SSRIs, common symptoms associated with SSRI use, SSRI implications on quality of life, and SSRI research.
Gain an understanding of the uses, and pharmacokinetics of, various anticoagulants and recognize considerations for prescribers and upcoming research.
Learn about Serotonin and Norepinephrine Reuptake Inhibitors (SNRI) use for depression, including pharmacokinetics, mechanism of action, side effects, and nursing implications. Upon completion, nurses will be able to.
Designed primarily for the nurse clinician working in adult care settings, this course explores the inner workings of the immune and endocrine systems to the role corticosteroids play in treating acute and chronic inflammatory diseases. It also covers the latest clinical practice guidelines on corticosteroid use.
Gain foundational knowledge of advancements in antiarrhythmic drugs (AAD) therapy, the pharmacokinetics and pharmacodynamics involved in treating arrhythmias, the management of drug overdoses, and challenges posed by various antiarrhythmic drugs.
